Michel Rivoire
Overview
Explore the profile of Michel Rivoire including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
1675
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hernandez C, Verzeroli C, Roca-Suarez A, Farca-Luna A, Tonon L, Esteban-Fabro R, et al.
JHEP Rep
. 2024 Dec;
7(1):101245.
PMID: 39717507
Background & Aims: Owing to unexplained interpatient variation and treatment failure in hepatocellular carcinoma (HCC), novel therapeutic approaches remain an urgent clinical need. Hepatic neurons, belonging to the autonomic nervous...
2.
Pastor F, Charles E, Di Vona C, Chapelle M, Rivoire M, Passot G, et al.
PLoS One
. 2024 Oct;
19(10):e0311655.
PMID: 39405283
The genome of Hepatitis B virus (HBV) persists in infected hepatocytes as a nuclear episome (cccDNA) that is responsible for the transcription of viral genes and viral rebound, following antiviral...
3.
Roca Suarez A, Plissonnier M, Michelet M, Dubois A, Heintz S, Saez-Palma M, et al.
STAR Protoc
. 2024 Oct;
5(4):103359.
PMID: 39368096
The liver microenvironment contains a wide variety of monocyte and macrophage populations. Here, we present a protocol for the specific isolation of liver-resident macrophages, known as Kupffer cells (KCs), from...
4.
Zager J, Orloff M, Ferrucci P, Choi J, Eschelman D, Glazer E, et al.
Ann Surg Oncol
. 2024 Jul;
31(12):8262-8263.
PMID: 39026142
No abstract available.
5.
Pastor F, Charles E, Belmudes L, Chabrolles H, Cescato M, Rivoire M, et al.
Front Microbiol
. 2024 Jun;
15:1415449.
PMID: 38841065
Phosphorylation is a major post-translation modification (PTM) of proteins which is finely tuned by the activity of several hundred kinases and phosphatases. It controls most if not all cellular pathways...
6.
Chapus F, Giraud G, Huchon P, Roda M, Grand X, Charre C, et al.
J Hepatol
. 2024 May;
81(4):609-620.
PMID: 38782119
Background & Aims: Transcription termination fine-tunes gene expression and contributes to the specification of RNA function in eukaryotic cells. Transcription termination of HBV is subject to the recognition of the...
7.
Zager J, Orloff M, Ferrucci P, Choi J, Eschelman D, Glazer E, et al.
Ann Surg Oncol
. 2024 May;
31(8):5340-5351.
PMID: 38704501
Background: Uveal melanoma (UM) has a poor prognosis once liver metastases occur. The melphalan/Hepatic Delivery System (melphalan/HDS) is a drug/device combination used for liver-directed treatment of metastatic UM (mUM) patients....
8.
Roca Suarez A, Plissonnier M, Grand X, Michelet M, Giraud G, Saez-Palma M, et al.
Gut
. 2024 May;
73(12):2012-2022.
PMID: 38697771
Objective: Achieving HBV cure will require novel combination therapies of direct-acting antivirals and immunomodulatory agents. In this context, the toll-like receptor 8 (TLR8) agonist selgantolimod (SLGN) has been investigated in...
9.
De Crignis L, Guesnon M, Morin A, Aleksic I, Rivoire M, Meeus P, et al.
Eur J Surg Oncol
. 2024 Mar;
50(6):108253.
PMID: 38552418
Background And Objective: For tumors involving inferior vena cava (IVC), surgery with complete resection remains the first line treatment. Management of IVC after resection, either ligation without reconstruction or primary...
10.
Evrard S, Bellera C, Desolneux G, Cantarel C, Toulza E, Faucheron J, et al.
Eur J Surg Oncol
. 2023 Nov;
49(11):107015.
PMID: 37949519
Background: Anastomotic leakage (AL) remains a major cause of morbidity following total mesorectal excision (TME). A diverting ileostomy reduces the risk of AL but impairs quality of life (QoL). Delayed...